So it appears that the decision is now out on the case against Myriad’s patents on the BRCA diagnostic testing. I haven’t read the decision yet, I saw a great stream of tidbits coming from @genomicslawyer, Dan Vorhaus. Check out the whole thing, starting around here and working upwards:
This made me laugh, as it is quite true and I’m sure we’ll be seeing the Genoscenti discuss this very soon:
RT @matthewherper: @genomicslawyer as expected. Genoscenti will be disappointed.
I think this is probably the best assessment of it so far though:
RT @genomicslawyer: Plenty of material here for critics/fans of gene patents, SCOTUS & Congress. Little chance this is last word.
I’d put money on this, for sure….
(cross-posted to Genomes Are Us)
UPDATES with other coverage: UPDATE 1-Myriad can patent breast cancer genes – court
RT @ScienceInsider U.S. Appeals Court Backs Gene Patents in Myriad Case http://bit.ly/mVCrm9
UPDATE: The detailed analysis begins to roll in. You should check out this post from @genomicslawyer Dan Vorhaus and John Conley, on this decision: Pigs Return to Earth: Federal Circuit Reinstates Most—But Not All—of Myriad’s Patents